Abstract:Background: Recent studies have reported the tumor suppressive role of miR-5195-3p in the progression of several cancers, but the potential roles of miR-5195-3p in ovarian cancer (OC) remain largely unknown. Methods: We first analyzed the expression levels of miR-5195-3p in 83 pairs of human OC tissues and adjacent specimens by reverse transcription-quantitative PCR. The correlation of miR-5195-3p/rhomboid domain containing 1 (RHBDD1) and clinicopathological parameters was analyzed by chi-square test. The prognostic value of miR-5195-3p was evaluated by Kaplan-Meier method Cox proportional hazards models. The effects of miR-5195-3p on cell proliferation, cell cycle distribution, migration and invasion were examined by CCK-8 assay, colony formation assay, flow cytometry and transwell assay. Tumor forming was evaluated by nude mice model in vivo. The association between miR-5195-3p and RHBDD1 was verified by luciferase reporter assay. Results: We observed that miR-5195-3p level was remarkably reduced in OC tissues as compared to adjacent tissues. The expression of miR-5195-3p was associated with FIGO stage, depth of invasion and poor survival prognosis in OC patients. Overexpression of miR-5195-3p significantly suppressed cell proliferation, cell cycle G1/S transition, migration and invasion in OC cell lines (SKOV-3 and OVCAR3), while knockdown of miR-5195-3p obtained the opposite results. We further confirmed miR-5195-3p as a negative post-transcriptional modulator of RHBDD1. RHBDD1 expression was upregulated in OC tissues compared with adjacent tissues, which was inversely correlated with miR-5195-3p expression. The expression of RHBDD1 was associated with FIGO stage and distant metastasis. RHBDD1 overexpression reversed the suppressive role of miR-5195-3p on OC cell proliferation, migration and invasion. Consistent with the in vitro results, miR-5195-3p overexpression decreased the growth of subcutaneously inoculated tumors in nude mice. Conclusions: Taken together, the present results indicated that miR-5195-3p acts a tumor suppressor by targeting RHBDD1 in OC.

MicroRNA-363 Inhibits Ovarian Cancer Progression by Inhibiting NOB1.

Mirna-612 Suppresses Ovarian Cancer Cell Tumorigenicity by Downregulating NOB1

MicroRNA-612 Inhibits Cervical Cancer Progression by Targeting NOB1

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

Microrna-215 Targets Nob1 and Inhibits Growth and Invasion of Epithelial Ovarian Cancer

MicroRNA-363-3p Downregulation in Papillary Thyroid Cancer Inhibits Tumor Progression by Targeting NOB1.

RNAi-mediated Downregulation of NOB1 Suppresses the Growth and Colony-Formation Ability of Human Ovarian Cancer Cells

MiR-139-3p Induces Cell Apoptosis and Inhibits Metastasis of Cervical Cancer by Targeting NOB1.

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer

MicroRNA-181 Functions As an Antioncogene and Mediates NF-κB Pathway by Targeting RTKN2 in Ovarian Cancers

Inhibition of NOB1 by Microrna-330-5p Overexpression Represses Cell Growth of Non-Small Cell Lung Cancer.

MiR-143-3p Suppresses the Progression of Ovarian Cancer.

LINC01088 Inhibits Tumorigenesis of Ovarian Epithelial Cells by Targeting Mir-24-1-5p

Inhibition of Long Non-Coding RNA XIST Upregulates Microrna-149-3p to Repress Ovarian Cancer Cell Progression

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

MicroRNA-326 Functions As a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)

MicroRNA-326 Functions As a Tumor Suppressor in Colorectal Cancer by Targeting the Nin One Binding Protein.

LMNB1 deletion in ovarian cancer inhibits the proliferation and metastasis of tumor cells through PI3K/Akt pathway

Long Noncoding RNA NBAT-1 Suppresses Tumorigenesis and Predicts Favorable Prognosis in Ovarian Cancer.

Lentivirus-Mediated Knockdown of NOB1 Suppresses the Proliferation of Colon Cancer Cells

Long Non-coding RNA FOXD2-AS1 Silencing Inhibits Malignant Behaviors of Ovarian Cancer Cells Via miR-324-3p/SOX4 Signaling Axis